Full Description
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress.
-
- 電子書籍
- 幼女戦記(8) 角川コミックス・エース
-
- DVD
- ファーザーズ・デイ



